Low-Field Cardiac Magnetic Resonance Imaging

C ardiac magnetic resonance (CMR) is arguably unmatched in its ability to evaluate cardiovascular structure and function, to characterize myocardial tissue by a wide variety of mechanisms, and to quantitatively assess blood flow and perfusion without the use of radiation or the need for invasive catheterization. CMR research and development continues at a rapid pace both in academia and by commercial vendors, and every year, new techniques are put forth that improve on existing applications and provide new capabilities that further expand the clinical utility of this powerful modality. Real-time and single-shot techniques have made CMR feasible in patients with rhythm irregularities and inability to breath-hold. Ongoing development and regulatory approval of magnetic resonance imaging (MRI) conditional pacemakers and implanted cardioverter defibrillators continues to grow the patient population amenable to CMR. 2] It is clear that those involved in CMR research must not only engage in developing new and exciting applications made feasible by technological advances, but must also ask whether their technology will promote the routine clinical utilization of CMR beyond academic and isolated private centers. There are many factors at play in answering this question, but important considerations must be affordability and ease of use.